Elon Musk has announced that the inaugural recipient of a brain chip implant from his brain-computer interface firm Neuralink has seemingly made a complete recovery, demonstrating the ability to manipulate a computer mouse through thought alone.
During a Spaces event on X, Musk expressed satisfaction with the progress, stating, “Progress is good, and the patient seems to have made a full recovery, with neural effects that we are aware of. The patient is able to move a mouse around the screen by just thinking.”
Additionally, Musk disclosed that Neuralink is presently focused on maximizing the number of mouse button clicks achievable through the patient’s thoughts.
Following regulatory approval for human trial recruitment in September of the preceding year, Neuralink successfully performed its inaugural chip implantation procedure on a human subject last month.
Musk revealed that the company’s maiden offering, dubbed Telepathy, aims to enable control of electronic devices such as phones or computers through mere thought.
In November of the prior year, Neuralink augmented its financial standing by securing an extra $43 million in venture capital, as per documentation filed with the US Securities and Exchange Commission (SEC).
The filing disclosed a boost from the company’s prior funding round, spearheaded by Peter Thiel’s Founders Fund, which escalated from $280 million to $323 million in early August.
